Whale bid increased to 67M at .0003 - watch closely for
Whale bid increased to 67M at .0003 - watch closely for this to get run up at any point over the coming days / weeks by the whales that got the .0004s and .0003s a few weeks back.
If the iHub shorter / bashers get caught on the hop like they did in September last year at the .0005/6 point when they tried holding it back , we get another short squeeze. Went on to a .0010 break in a few days then on to .0033. Full back story in the contemporaneous trading record here.
Tersis Technologies, Inc. (TERS) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...
Continue Reading
A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...
Continue Reading
Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...
Continue Reading
Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...
Continue Reading
Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....
Continue Reading
An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...
Continue Reading
Rethinking Fire Safety with a Global Mindset The 2026 World Fire Congress wrapped up in London, signaling a big shift in how we tackle fire safety. Over 60 nations were represented, and they all walked away singing the same tune: if we’re going to handle these ever-mounting fire risks, we have to lean on each other a lot more. Next stop on this crusade? The flashy city...
Continue Reading
Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...
Continue Reading
New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...
Continue Reading
Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...
Continue Reading
Top 5 Most Recently Viewed Articles
Wage Inequality: An Expanding Challenge for Low-Income Workers Recent research has unveiled troubling trends regarding wage inequality, particularly affecting low-income workers. Reports indicate that while incomes for high earners continue to soar, those at the bottom end of the wage spectrum are struggling to keep pace. This growing disparity raises concerns about...
Continue Reading
Centene Corporation Faces New Lawsuit Over Securities Fraud Investors of Centene Corporation, known by the ticker symbol CNC, have found themselves at the center of a securities fraud lawsuit. Recently, a leading law firm announced the initiation of legal action against Centene Corporation and some of its senior executives. This lawsuit stems from alleged violations of...
Continue Reading
Michael Saylor's Call for Bitcoin Acquisition Bitcoin has gained significant attention as a revolutionary financial asset, and one of its most vocal proponents is Michael Saylor. The Executive Chairman and co-founder of Strategy (NASDAQ: MSTR) has recently expressed his belief that the U.S. government should actively accumulate Bitcoin (BTC) to tackle national debt and...
Continue Reading
Revolutionizing Ovarian Cancer Treatment Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company dedicated to advancing therapies for patients battling cancer, is excited to share pivotal details surrounding the results of its ongoing Phase 2 RAMP 201 trial. This promising clinical trial explores the efficacy of Avutometinib combined with Defactinib in treating...
Continue Reading
MySize Inc. Enhances AI Strategy for Retail and Fashion MySize, Inc. (NASDAQ: MYSZ), a leader in AI-powered technology solutions for the retail and fashion sectors, is intensifying its strategic initiative to develop a scalable platform that integrates innovative technologies. The company is keen on identifying and potentially acquiring businesses that align with its...
Continue Reading